80 related articles for article (PubMed ID: 10447444)
21. Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?
Derksen RH; de Groot PG
J Autoimmun; 2000 Sep; 15(2):255-9. PubMed ID: 10968920
[TBL] [Abstract][Full Text] [Related]
22. Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis.
Steen KS; Peters MJ; Zweegman S; de Groot PG; Voskuyl AE
J Clin Rheumatol; 2007 Apr; 13(2):92-3. PubMed ID: 17414539
[TBL] [Abstract][Full Text] [Related]
23. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
[TBL] [Abstract][Full Text] [Related]
24. [Duration of anticoagulant therapy and risk of recidivation of TEN--editorial].
Malý J
Vnitr Lek; 2007 Jun; 53(6):629-31. PubMed ID: 17702121
[No Abstract] [Full Text] [Related]
25. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Malik V; Kupfer Y; Tessler S
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
[No Abstract] [Full Text] [Related]
26. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Brotman DJ
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
[No Abstract] [Full Text] [Related]
27. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
Caprini JA
Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
[No Abstract] [Full Text] [Related]
28. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
Abdel-Razeq HN; Radwi GR
Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
[No Abstract] [Full Text] [Related]
29. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
[No Abstract] [Full Text] [Related]
30. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
[TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
Anderson DR
J Thromb Haemost; 2005 May; 3(5):846-7. PubMed ID: 15869574
[No Abstract] [Full Text] [Related]
32. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Tran HA
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
[No Abstract] [Full Text] [Related]
33. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
34. [Postoperative recurrence of venous thromboembolism in patients with episodes of preoperative thromboembolism].
Kuroiwa M; Arai M; Nakahara E; Hoka S
Masui; 2003 Jul; 52(7):744-9. PubMed ID: 12910975
[TBL] [Abstract][Full Text] [Related]
35. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
36. Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome.
Sucker C; Wenzel F; Zotz RB; Hetzel GR; Scharf RE
J Rheumatol; 2006 Sep; 33(9):1881-2. PubMed ID: 16881092
[TBL] [Abstract][Full Text] [Related]
37. Duration of anticoagulation: decision making based on absolute risk.
Keeling D
Blood Rev; 2006 May; 20(3):173-8. PubMed ID: 16271810
[TBL] [Abstract][Full Text] [Related]
38. Insufficient evidence supporting low-intensity warfarin for venous thromboembolism (VTE) prophylaxis.
Cundiff DK
MedGenMed; 2003 Jul; 5(3):2. PubMed ID: 14600639
[No Abstract] [Full Text] [Related]
39. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
Agnelli G; Cimminiello C
Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
[No Abstract] [Full Text] [Related]
40. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
Aujesky D; Smith KJ; Roberts MS
Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
